Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CureFAKtor Pharmaceuticals LLC
DescriptionFocal adhesion kinase (FAK) inhibitor of VEGF receptor 3 (FLT4)
Molecular Target Focal adhesion kinase (FAK) ; Vascular endothelial growth factor (VEGF) receptor 3 (FLT4) (VEGFR-3)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation U.S. - Orphan Drug (Treat pancreatic cancer)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today